These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2603509)

  • 21. Long-term versus short-term amitriptyline side effects as measured by a postmarketing surveillance system.
    Bryant SG; Fisher S; Kluge RM
    J Clin Psychopharmacol; 1987 Apr; 7(2):78-82. PubMed ID: 3584525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scientific challenges in postmarketing surveillance of ocular adverse drug reactions.
    Fraunfelder FW; Fraunfelder FT
    Am J Ophthalmol; 2007 Jan; 143(1):145-149. PubMed ID: 17188050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical trial--observation studies in general practice].
    Kleinsorge H
    Verh Dtsch Ges Inn Med; 1988; 94():431-6. PubMed ID: 3061215
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the therapeutic value of drugs--a task of clinical pharmacology].
    Herken H; Abshagen U
    Gynakologe; 1988 Mar; 21(1):14-20. PubMed ID: 3371753
    [No Abstract]   [Full Text] [Related]  

  • 25. [Postmarketing surveillance of benazepril-related cough and related risk factors analysis on hypertensives].
    Lu J; Li LM; Cao WH; Zhan SY; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):401-5. PubMed ID: 12820937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ofloxacin induced arthropathy in patients with multi-drug resistance tuberculosis.
    Tumbanatham A; Vinodkumar S
    J Assoc Physicians India; 2000 Jun; 48(6):647-8. PubMed ID: 11273550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect and tolerance of ofloxacin in bronchopulmonary infections in comparison with amoxicillin].
    Chuard C; Regamey C
    Schweiz Med Wochenschr; 1989 Dec; 119(52):1913-6. PubMed ID: 2692153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute renal failure due to ofloxacin.
    Espiritu J; Walton T
    W V Med J; 1995 Jan; 91(1):16. PubMed ID: 7856152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacovigilance of self-medication].
    Montastruc JL; Bagheri H; Geraud T; Lapeyre-Mestre M
    Therapie; 1997; 52(2):105-10. PubMed ID: 9231503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Documentation and assessment of adverse drug effects with ofloxacin as an example].
    Esch B; Paeschke N; Christ W; Kreutz G
    Infection; 1991; 19 Suppl 1():S9-12. PubMed ID: 2007521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proactive safety surveillance.
    Bortnichak EA; Wise RP; Salive ME; Tilson HH
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):191-6. PubMed ID: 11501330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
    Stöhr W; Paulides M; Bielack S; Jürgens H; Treuner J; Rossi R; Langer T; Beck JD
    Pediatr Blood Cancer; 2007 Apr; 48(4):447-52. PubMed ID: 16628552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
    Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
    Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Do tendon lesions occur during quinolone administration?].
    Shah P
    Dtsch Med Wochenschr; 2003 Oct; 128(42):2214. PubMed ID: 14562223
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
    Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
    Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Musculoskeletal clinical adverse effects of ofloxacin].
    Martín Marco A; Falquera Sacrest M; Rubio Cabàllero M
    Med Clin (Barc); 1999 Nov; 113(16):635-6. PubMed ID: 10609260
    [No Abstract]   [Full Text] [Related]  

  • 38. [Convulsions during prolonged treatment with ofloxacin].
    Bercault N; Demasure M; Benhamou CL; Gueveler C
    Rev Med Interne; 1993 Mar; 14(3):194. PubMed ID: 8378644
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use-risk consideration of anti-infective agents from the point of view of the licensing authority].
    Christ W; Esch B
    Infection; 1991; 19 Suppl 1():S65-71. PubMed ID: 2007519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Side effects caused by ofloxacin: status of knowledge before legalization and changes caused by spontaneous reports thereafter].
    Esch B; Paeschke N; Christ W; Kreutz G
    Verh Dtsch Ges Inn Med; 1989; 95():717-21. PubMed ID: 2603509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.